Scout | FOR-FD-25-006: Studies Addressing Rare Neurodegenerative Diseases including ALS

grant

Studies Addressing Rare Neurodegenerative Diseases including ALS

FOR-FD-25-006

Summary

This grant aims to fund research that helps develop medical products to prevent, diagnose, or treat ALS and other rare neurodegenerative diseases in both adults and children. The goal is to fill important knowledge gaps and significantly impact the understanding and treatment of these diseases, benefiting current or future product development.

The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these st…

Source

Agency: Food and Drug Administration

Eligibility

State governments

Special district governments

Small businesses

City or township governments

Native American tribal organizations (other than Federally recognized tribal governments)

Private institutions of higher education

For profit organizations other than small businesses

County governments

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Public and State controlled institutions of higher education

Native American tribal governments (Federally recognized)

Public housing authorities/Indian housing authorities

Independent school districts

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

Supporting links

grants.gov

Studies Addressing Rare Neurodegenerative Diseases including ALS

Source

Eligibility

Tags

Supporting links

Similar opportunities